Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Valerio, B. Schreiber, C. Handler, C. Denton, J. Coghlan (London, United Kingdom). Does lung function predict response to therapy in PAH associated with connective tissue disease?. Eur Respir J 2012; 40: Suppl. 56, 3928

Member's Comments

No comment yet.

Related content which might interest you: Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy}, Source: Eur Respir J 2012; 40: 641-648 Year: 2012 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Undifferentiated connective tissue disease at risk for systemic sclerosis: is heart function already impaired? Source: International Congress 2017 – PAH and CTEPH Year: 2017 Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27 Year: 2005 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Distance assessment of the risk of pulmonary hypertension associated with connective tissue diseases: do biomarkers help? Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Chemical exposure triggering connective tissue disease with lung involvement Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 From life threatening to chronic connective tissue disease-associated interstitial lung disease: all you need to know Source: Virtual Congress 2020 – From life threatening to chronic connective tissue disease-associated interstitial lung disease (CTD-ILD): all you need to know Year: 2020 Severe fibrotic lung disease – How much therapy is too much therapy? Source: Annual Congress 2008 - Clinical Grand Round - an interactive session Year: 2008 The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=1 Year: 2005 Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The effect of corticosteroid use on skeletal muscle function in patients with interstitial lung disease Source: Annual Congress 2012 - The latest insights in integrated care Year: 2012 Effect of pulmonary rehabilitation on systemic inflammatory markers, muscle cross section area and functional parameters in interstitial lung disease Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012